Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti ...

National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical ...

Bristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration (FDA) for Opdivo to treat adults ...

Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment specifically targeting cold agglutinin disease (CAD), a rare B-cell ...

At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.

Resolution plans to use Series B investment to advance the development of its macrophage therapies in inflammatory and ...

Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens ...

Novo Nordisk’s chief scientific officer Marcus Schindler led the keynote address at ELRIG Drug Discovery 2024 in London, UK.